GSK-LSD1 2HCl 21670 33 μM) is comparable to

33 μM) is comparable to its potency against RNA cleavage in vitro

and anti-glycation agents

These effects appear to be due to halofuginone-mediated inhibition of the collagen type I and MMP-2 promoters

J Clin Virol

GSK-LSD1 2HCl 21670 33 μM) is comparable toGSK LSD1 2HCl is a selective inhibitor of LSD1 with IC50 value of 16 nM . Lysine (K) specific demethylase 1A (LSD1) is a flavin dependent histone demethylase that demethylates mono and di methylated lysines and plays an important role in oocyte growth, embryogenesis and tissue specific differentiation. LSD1 plays a role in acute myeloid leukemia (AML). GSK LSD1 2HCl irreversibly inhibited LSD1 with IC50 value of 16 nM and is > 1000 fold selective over